Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose

BACKGROUND AND AIMS: The duration of protection from hepatitis B vaccination in children and adults is not known. In 1981, we used three doses of plasma‐derived hepatitis B vaccine to immunize a cohort of 1578 Alaska Native adults and children from 15 Alaska communities who were ≥6 months old. APPRO...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruce, Michael G., Bruden, Dana, Hurlburt, Debby, Morris, Julie, Bressler, Sara, Thompson, Gail, Lecy, Danielle, Rudolph, Karen, Bulkow, Lisa, Hennessy, Thomas, Simons, Brenna C., Weng, Mark K., Nelson, Noele, McMahon, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790192/
https://www.ncbi.nlm.nih.gov/pubmed/35320592
http://dx.doi.org/10.1002/hep.32474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790192/
https://www.ncbi.nlm.nih.gov/pubmed/35320592
http://dx.doi.org/10.1002/hep.32474

Ejemplares similares